Unknown

Dataset Information

0

Rivaroxaban, a specific FXa inhibitor, improved endothelium-dependent relaxation of aortic segments in diabetic mice.


ABSTRACT: Activated factor X (FXa) plays a central role in the coagulation cascade, while it also mediates vascular function through activation of protease-activated receptors (PARs). Here, we examined whether inhibition of FXa by rivaroxaban, a direct FXa inhibitor, attenuates endothelial dysfunction in streptozotocin (STZ)-induced diabetic mice. Induction of diabetes increased the expression of a major FXa receptor, PAR2, in the aorta (P?

SUBMITTER: Pham PT 

PROVIDER: S-EPMC6672013 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Rivaroxaban, a specific FXa inhibitor, improved endothelium-dependent relaxation of aortic segments in diabetic mice.

Pham Phuong Tran PT   Fukuda Daiju D   Yagi Shusuke S   Kusunose Kenya K   Yamada Hirotsugu H   Soeki Takeshi T   Shimabukuro Michio M   Sata Masataka M  

Scientific reports 20190801 1


Activated factor X (FXa) plays a central role in the coagulation cascade, while it also mediates vascular function through activation of protease-activated receptors (PARs). Here, we examined whether inhibition of FXa by rivaroxaban, a direct FXa inhibitor, attenuates endothelial dysfunction in streptozotocin (STZ)-induced diabetic mice. Induction of diabetes increased the expression of a major FXa receptor, PAR2, in the aorta (P < 0.05). Administration of rivaroxaban (10 mg/kg/day) to diabetic  ...[more]

Similar Datasets

| S-EPMC1572325 | biostudies-literature
| S-EPMC7402225 | biostudies-literature
| S-EPMC3819278 | biostudies-literature
| S-EPMC4644902 | biostudies-other
| S-EPMC4002686 | biostudies-other
| S-EPMC2551689 | biostudies-literature
| S-EPMC2014730 | biostudies-literature
| S-EPMC4233640 | biostudies-literature
| S-EPMC6854321 | biostudies-literature
| S-EPMC6817488 | biostudies-literature